SS
OPNT

Steve Schonfeld’s Opiant Pharmaceuticals, Inc. Common Stock OPNT Stock Holding History

Steve Schonfeld’s Portfolio OPNT Stock Details OPNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-42,300
Closed -$858K – 2949
2022
Q4 		$858K Buy
+42,300
New +$648K 0.01% 1233

Steve Schonfeld's OPNT Position: Q1 2023 in Review

Steve Schonfeld sold out of Opiant Pharmaceuticals, Inc. Common Stock (OPNT) in Q1 2023, closing a stake of 42,300 shares — an estimated $858K sold.

Steve Schonfeld first reported a position in OPNT in Q4 2022 and held it in 1 quarter. The position peaked at $858K in Q4 2022. 0 funds tracked by Wall St. Rank hold OPNT as of Q1 2023.

  • Steve Schonfeld reported no remaining Opiant Pharmaceuticals, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Steve Schonfeld sold 42,300 Opiant Pharmaceuticals, Inc. Common Stock shares in Q1 2023, an estimated $858K.
  • Steve Schonfeld first reported a position in Opiant Pharmaceuticals, Inc. Common Stock in Q4 2022 and held it in 1 quarter.
  • Steve Schonfeld's Opiant Pharmaceuticals, Inc. Common Stock position peaked at $858K in Q4 2022.
  • 0 funds tracked by Wall St. Rank held Opiant Pharmaceuticals, Inc. Common Stock as of Q1 2023.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2023, filed 15 May 2023.